We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




RNA Silencing May Protect Against Viral Infection

By Biotechdaily staff writers
Posted on 09 Jun 2002
Recently published research describes the use of "RNA silencing” by animal cells to defend against viral infections. More...
The findings appear in the cover story in the May 17, 2002, issue of Science.

RNA silencing regulates gene expression by specific degradation of that gene's mRNA. After activation, the RNA silencing mechanism has ‘memory,” recognizing which RNA nucleotide sequences to destroy.

"In our experiments, we infected fruit fly cells with an RNA virus,” said Dr. Shou-Wei Ding, assistant professor of plant pathology at the University of California (Riverside, USA). "This triggered strong silencing of the viral RNAs in the fly cells. We further demonstrated that the same virus also directs expression of a protein that suppresses RNA silencing in the fly cells, thus ensuring successful infections.”

RNA silencing has been shown to be a common antiviral mechanism in plants since it was first discovered in transgenic plants in 1990. That it also functions in animal cells suggests the existence of a highly conserved antiviral pathway shared by the animal and plant kingdoms.

The new findings may lead to the development of new treatments for recalcitrant human and animal viral diseases based on the RNA silencing adaptive defense, which differs from adaptive immunity that targets protein antigens of viruses. "For example, blocking the action of viral silencing suppressors should lead to rapid virus elimination by the cell's own antiviral defense,” said Ding.




Related Links:
UC Riverside

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
HPV Test
Allplex HPV28 Detection
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.